Esperion Therapeutics (ESPR) - NASDAQ
Company Description
Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers.... More
Sector: Healthcare
Industry: Biotechnology
Country: United States